Gimatecan (Sigma-Tau Industrie Farmaceutiche Riunite/Novartis)
IDrugs 2005, $article.volume.volumeNumber:578-588 (21 June 2005)
Access to the PDF and full text of this article requires a subscription 
(the abstract is freely accessible)
Existing subscribers
If you have trouble accessing your subscription, email us: info@biomedcentral.com